US Stocks

Relmada Therapeutics, Inc.

Relmada Therapeutics is a biotech company that specializes in developing treatments for CNS diseases and other disorders. Its flagship product is Esmethadone, an N-methyl-D-aspartate receptor antagonist used to treat major depressive disorder in adults. Founded in 2004, the company is headquartered in Coral Gables, Florida.